Groundbreaking mRNA vaccine administered to captive elephant to fight EEHV

FHS
July 13, 2024
4:38 am

Colossal, the de-extinction company, announces that the mRNA vaccine it helped to provide research support and acceleration funding for has been administered to the first elephant in captivity.

The Psychedelic Drug Development Pipeline: Bullseye Chart Year-End 2023 – Psychedelic Alpha

In early 2023, we visualised our Psychedelics Drug Development Tracker data in a ‘bullseye chart’ format as part of 2022’s Year in Review. Due to its

February 6, 2024

Many Patients With CKD Never Receive a Diagnosis

LONG BEACH, Calif. — Despite seeing a healthcare provider, nearly a third of individuals with chronic kidney disease (CKD) went undiagnosed, researchers uncovered. Roughly 2.85

May 20, 2024

Codagenix pursues RSV vaccine development amid unexpected challenges – Pharmaceutical Technology

The reason for the trial delay was related to an issue with finding seropositive older toddlers due to the isolation of this age group during

August 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.